Summary
32 / 100 · Bulios Score
What speaks for it
- Revenue grew by 52% a year over the last 3 years.
- Analysts expect revenue to grow by 27% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- The share price is above the Bulios Fair Price.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 40% a year over 5 years. Over the last 3 years it grew by 52% a year. For the next fiscal year analysts expect revenue to grow by 27%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $43.6M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 11
- Hold 3
- Sell 7
Today's price within the analysts' price targets
The average target of $9 is 196% above today's price. 52% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product Revenue 62%
- Royalty 37%
- Service 1.2%
By region
The company reports no revenue by region.
Product Revenue brings in 62% of revenue. Royalty grew fastest, by 102% a year.
Segments in detail